U.S. DHHS - BARDA: Advanced Research and Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasures (BAA) – White paper

Name: U.S. DHHS - BARDA: Advanced Research and Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasures (BAA) – White paper
Application deadline: 30/09/17
General description:

Aim: advanced research and development of medical countermeasures for chemical, biological, radiological, and nuclear agents, focused on: 1. Vaccines 2. Antitoxins and Therapeutics Proteins 3. Antimicrobial Therapeutics 4. Radiological / Nuclear Threat Medical Countermeasures 5. Chemical Threat Medical Countermeasures 6. Clinical Diagnostics. Efforts proposed may include activities in Non-Clinical Research Development, Process Development, Formulation, and Manufacturing Development, and Clinical Evaluation.

https://goo.gl/ocMc6V

 

Source: Foreign
Contact person: Robi, 2152, robertg@trdf.technion.ac.il; Michal - 1745, michall@trdf.technion.ac.il
Fields: Life Sciences and medicine,Exact sciences and IT Field
Type of fund: The fund is not a competitive fund
Related fund and profiles: U.S. Dep. of Health and Human Serv.-Biomed. Adv. R&D Authority (BARDA) ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)